High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.8M
$8,780,668
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IRD |
Opus Genetics, Inc.
|
COO
Sell to Cover
|
2026-03-16 | $19,525 | S | Form 4 |
|
IRD
S
Opus Genetics, Inc.
Jayagopal Ashwath
• Officer • Chief Scientific & Dev. Ofc.
Sell to Cover
2026-03-16
$19,046
|
||||||
| IRD |
Opus Genetics, Inc.
|
Officer • Chief Scientific & Dev. Ofc.
Sell to Cover
|
2026-03-16 | $19,046 | S | Form 4 |
| IRD |
Opus Genetics, Inc.
|
CEO
Sell to Cover
|
2026-03-16 | $127,327 | S | Form 4 |
|
IRD
S
Opus Genetics, Inc.
Zaremba Rabourn Amy
• Officer • Head of Fin. Quality Assurance
Sell to Cover
2026-03-16
$14,770
|
||||||
| IRD |
Opus Genetics, Inc.
|
Officer • Head of Fin. Quality Assurance
Sell to Cover
|
2026-03-16 | $14,770 | S | Form 4 |
| IRD |
Opus Genetics, Inc.
|
Director
Discretionary SellΔOwn -42.1%
|
2025-12-09 | $8,600,000Whale | S | Form 4 |